SCHEMBL6493950

SCHEMBL6493950

Nc1ccc(-c2nc3ccc(N)c(Cl)c3[nH]2)cc1Cl

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 11/20 0.63
▸ MEN1 O00255 10/20 0.63
▸ KMT2A Q03164 10/20 0.63
▸ MAPT P10636 10/20 0.63
▸ KDM4E B2RXH2 9/20 0.63
▸ SMN1; SMN2 Q16637 8/20 0.63
▸ NPC1 O15118 8/20 0.63
▸ RAB9A P51151 8/20 0.63
▸ GAA P10253 8/20 0.63
▸ HPGD P15428 7/20 0.63
▸ POLB P06746 5/20 0.63
▸ TP53 P04637 4/20 0.63
▸ CACNA1B Q00975 3/20 0.63
▸ APBA1 Q02410 3/20 0.63
▸ USP2 O75604 3/20 0.63
▸ THRB P10828 2/20 0.63
▸ TDP1 Q9NUW8 2/20 0.63
▸ LMNA P02545 2/20 0.63
▸ CYP3A4 P08684 3/20 0.46
▸ MAPK1 P28482 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6494902 0.84 SMN1; SMN2 (0.59) ALDH1A1MEN1KMT2AMAPTKDM4E
SCHEMBL6483421 0.78 MEN1 (1.00) ALDH1A1MEN1KMT2AMAPTKDM4E
SCHEMBL6482050 0.77 ALDH1A1 (0.58) ALDH1A1MEN1KMT2AMAPTKDM4E
SCHEMBL6483081 0.77 ALDH1A1 (0.50) ALDH1A1MEN1KMT2AMAPTKDM4E
SCHEMBL6483072 0.77 ALDH1A1 (0.50) ALDH1A1MEN1KMT2AMAPTKDM4E
SCHEMBL6493952 0.76 ALDH1A1 (0.73) ALDH1A1MEN1KMT2AMAPTKDM4E
SCHEMBL6483416 0.75 ALDH1A1 (0.79) ALDH1A1MEN1KMT2AMAPTKDM4E
SCHEMBL28257887 0.70 ALDH1A1 (0.61) ALDH1A1MEN1KMT2AMAPTKDM4E
SCHEMBL15176810 0.69 MAPT (0.47) ALDH1A1MEN1KMT2AMAPTKDM4E
SCHEMBL8536727 0.68 ALDH1A1 (0.52) ALDH1A1MEN1KMT2AMAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050260126-A1 Diagnostic probes and remedies for diseases with accumulation of prion protein, and stains for prion protein BF RESEARCH INSTITUTE (JP) 2005-11-24 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050260126-A1 Diagnostic probes and remedies for diseases with accumulation of prion protein, and stains for prion protein PRNP, PRPH, PCNP ALDH1A1 1577/4885MEN1 3565/4885KMT2A 3291/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback